Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) — Cash Flow Reinvestment Rate

Latest as of June 2025: 0.20x

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) has a Cash Flow Reinvestment Rate of 0.20x as of June 2025, reinvesting CN¥7.27 Million (capex CN¥7.27 Million ) from operating cash flow of CN¥36.25 Million. Explore Tonghua Golden-Horse Pharmaceutical Indu (000766) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.20x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥7.27 Million
Capex + Investments

Operating Cash Flow

CN¥36.25 Million
CNY

Capital Expenditures

CN¥7.27 Million
CNY

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Cash Flow Reinvestment Rate (2000–2025)

Historical reinvestment intensity for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd across 21 annual periods. Also explore 000766 asset base for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (2000–2025)

Year-by-year capital reinvestment analysis for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd. For live market cap and broader valuation context, see market cap of Tonghua Golden-Horse Pharmaceutical Indu.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2025 0.61x CN¥64.07 Million CN¥105.05 Million CN¥64.07 Million ▲ +1.0%
2024 0.60x CN¥98.30 Million CN¥162.75 Million CN¥49.17 Million ▼ -31.7%
2023 0.88x CN¥99.80 Million CN¥112.78 Million CN¥26.67 Million ▲ +611.4%
2022 0.12x CN¥24.65 Million CN¥198.16 Million CN¥23.74 Million ▼ -32.5%
2021 0.18x CN¥25.49 Million CN¥138.33 Million CN¥25.48 Million ▼ -97.1%
2020 6.40x CN¥516.17 Million CN¥80.71 Million CN¥19.16 Million ▼ -47.3%
2019 12.14x CN¥908.82 Million CN¥74.86 Million CN¥60.98 Million ▲ +772.1%
2018 1.39x CN¥237.66 Million CN¥170.72 Million CN¥74.40 Million ▼ -81.1%
2017 7.37x CN¥194.94 Million CN¥26.43 Million CN¥118.10 Million ▼ -58.5%
2016 17.77x CN¥1.61 Billion CN¥90.63 Million CN¥169.40 Million ▲ +232.5%
2014 5.34x CN¥183.39 Million CN¥34.32 Million CN¥183.39 Million ▲ +249.0%
2013 1.53x CN¥157.66 Million CN¥102.96 Million CN¥157.66 Million ▲ +336.0%
2010 0.35x CN¥10.20 Million CN¥29.05 Million CN¥10.20 Million ▲ +113.7%
2009 0.16x CN¥13.14 Million CN¥79.94 Million CN¥13.14 Million ▼ -77.5%
2008 0.73x CN¥7.48 Million CN¥10.26 Million CN¥7.48 Million ▲ +41.6%
2007 0.51x CN¥5.12 Million CN¥9.95 Million CN¥5.12 Million ▲ +4.8%
2005 0.49x CN¥17.55 Million CN¥35.74 Million CN¥17.55 Million ▲ +115.1%
2004 0.23x CN¥4.37 Million CN¥19.12 Million CN¥4.37 Million ▼ -74.6%
2003 0.90x CN¥82.57 Million CN¥91.99 Million CN¥82.57 Million ▲ +277.1%
2002 0.24x CN¥17.31 Million CN¥72.70 Million CN¥17.31 Million ▼ -87.0%
2000 1.84x CN¥360.49 Million CN¥196.15 Million CN¥360.49 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow